DRUG SAFETY EXPERT WITNESSES

Expert Witness: E-016039
This highly-qualified epidemiologist has extensive experience in the realm of drug safety. He received his BS from the University of British Columbia before earning his Pharm.D in clinical pharmacology from Idaho State University and his MS in clinical epidemiology from the University of Toronto. He subsequently completed a fellowship in pharmacoepidemiology at McGill University, serving as a postdoctoral fellow at the Baycrest Center for Geriatric Care and the Royal ...
Expert Witness: E-016039
This expert's research career has been focused in the area of drug safety. As a clinical epidemiologist and pharmacologist, he uses large administrative databases in Canada and the United States as the main data source for his research. In the last ten years he has made significant contributions to this area quantifying rare drug adverse events with popular prescription drugs. His research has been used by the FDA, Health Canada and European Medicines Agency
Expert Witness: E-010122
This expert is a pharmacist and a pharmacologist and a former professor at Yale University and Georgetown University. He is also a former FDA Medical Officer/Senior Medical Analyst, who is an expert in the areas of drug Safety, drug development, regulatory affairs and FDA policy. He as also served as an advisor on the 2016 Ted Cruz presidential campaign, and has also been invited to testify in front of the U.S. Senate as a healthcare policy expert, FDA expert and ...
Expert Witness: E-008530
This highly qualified Associate Professor earned a masters in Public Health in Epidemiology from the highly regarded Bloomberg School of Public Health. He is board certified in Internal Medicine. He has won many honors throughput his career including the Bruce Squires Award for the Best Research Paper. He is a member of numerous professional societies including the International Society of Pharmacoepidemiology. He serves as a reviewer for more than 50 peer-reviewed ...
Expert Witness: E-007175
This expert isProfessor and Head of the Department of Health Outcomes Research and Policy at a major university school of pharmacy. He holds a bachelors degree in pharmacy from the University of Wisconsin, and a PhD in Social, Administrative, and Clinical Pharmacy from the University of Minnesota. Prior to joining Auburn University he was Associate Professor of Pharmaceutical Outcomes and Policy in the Eshelman School of Pharmacy at the University of North Carolina. ...
Expert Witness: E-001445
This expert holds a doctorate degree in toxicology and has been a practicing toxicologist for over 40 years. Board certified by the American Board of Toxicology and a Fellow of the Academy of Toxicological Sciences, he had published over 35 scientific articles and is a former president of the Mid-Atlantic chapter of the Society of Toxicology. He spent over 30 years as a Director of Toxicology for two major pharmaceutical companies and currently serves as an independent ...
Expert Witness: E-009480
This expert is recognized as one of the country's top food safety trainers and has 25+ years experience as a food safety consultant in the food industry. Currently, he has recently retired as president and founder of an independent food service practice which provides consulting and training to food service and lodging companies throughout the United States, Canada, and the Caribbean. The expert was involved in the creation of the ServSafe instructional series which is ...
Expert Witness: E-006693
This human factors psychologist has nearly 30 years of experience as a safety analysis professional. She began her career as a Human Factors Psychologist with the U.S. Consumer Product Safety Commission (CPSC), and she currently owns and operates a firm that examines the design, instructions and warnings of consumer products. She conducts training for manufacturers on issues such as anticipating product hazards, consumer behavior, motivation & perceptions, foreseeable ...

DRUG SAFETY EXPERT WITNESS CASE STUDIES

Medical Device Manufacturer Allegedly Violates FDA Regulations DRUG SAFETY Expert Case

This case involves numerous plaintiffs who suffered complications related to a birth control medical device. The plaintiffs suffered perforation of the uterus and other organs, migration of the device throughout the body, as well as immune reactions to …

Patient Allegedly Develops Cancer From Prescription Drug Interaction DRUG SAFETY Expert Case

This case involves a 62-year-old man with erectile dysfunction who developed melanoma after taking ED medication for 1 year. It was alleged that a there was a link between the PDE-5 inhibitors present in the patient’s erectile dysfunction medication a …

Patient Develops Compulsive Behavior While Taking Antipsychotic Medication DRUG SAFETY Expert Case

This case involves a 26-year-old male patient with bipolar disorder and severe depression who was prescribed the antipsychotic aripipiprazole. This patient had a family history of bipolar disorder and alcoholism. While taking the antipsychotic medi …

Statistics Experts Review Data Sets In Pharmaceutical Drug Report DRUG SAFETY Expert Case

…  male children who developed gynecomastia after taking the drug risperidone. It was alleged that the pharmaceutical company that marketed this drug hid evidence that would have alerted clinicians and regulatory authorities …

Expert in Over-the-Counter Drug Labels Opines on Warning Standards DRUG SAFETY Expert Case

…  the diarrhetic by her doctor, and after taking the drug, she suffered from involuntary muscle movements and could not feel her …  on her multiple sclerosis. An expert in over-the-counter drug labels was sought to opine on the manner in which information should be …

Toxicology Experts Evaluate Excessive Opioid Prescriptions DRUG SAFETY Expert Case

Toxicology Experts Evaluate Excessive Opioid Prescriptions

…  more than 10 patients having died either as a result of drug abuse or acute overdose. The defending physician allegedly was aware that his patients were abusing the drugs he prescribed, and was prescribing much higher doses than what is …